Home/Filings/4/0001493152-23-002974
4//SEC Filing

McNulty Christopher 4

Accession 0001493152-23-002974

CIK 0000764195other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 5:01 PM ET

Size

6.4 KB

Accession

0001493152-23-002974

Insider Transaction Report

Form 4
Period: 2023-01-26
McNulty Christopher
CFO and Head of BD
Transactions
  • Award

    Option (Right to Buy Common Shares)

    2023-01-26+75,00075,000 total
    Exercise: $0.57Exp: 2033-01-26Common Shares (75,000 underlying)
Footnotes (2)
  • [F1]The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 26, 2023 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 26, 2023 (the "Option Agreement"). 25% of the options vest and become exercisable on the one-year anniversary of the Grant Date, with the remaining 75% of the options vesting and becoming exercisable in 24 equal monthly installments beginning on the first day of the month following the one-year anniversary of the Grant Date, subject to the reporting person's employment on the relevant vesting date.
  • [F2]The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.

Documents

1 file

Issuer

VBI Vaccines Inc/BC

CIK 0000764195

Entity typeother

Related Parties

1
  • filerCIK 0001701459

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 5:01 PM ET
Size
6.4 KB